FDA Approves Lilly’s weight-loss drug

Tirzepatide can now be prescribed for weight loss

Previously approved for diabetes treatment, tirzepatide now has the FDA’s approval for weight loss. Now known as Zepbound, the latest anti-obesity medication is the latest tool in doctors’ armamentarium.

Read more at Politico (subscription required)